BioCryst (BO1) Ownership - Who Owns BioCryst?
BioCryst (BO1) Ownership Overview
- 1.47% Insiders
- 15.39% Mutual Funds
- 0.87% Other Institutional Investors
- 18.95% ETFs
- 63.31% Public Companies and Individual Investors
The ownership structure of BioCryst (DE:BO1) stock is a mix of institutional, retail, and individual investors. Approximately 35.22% of the company’s stock is owned by Institutional Investors, 1.47% is owned by Insiders, and 63.31% is owned by Public Companies and Individual Investors.
The ownership structure of BioCryst (DE:BO1) stock is a mix of institutional, retail, and individual investors. Approximately 35.22% of the company’s stock is owned by Institutional Investors, 1.47% is owned by Insiders, and 63.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 18, 2026 | Amy E Mckee | $100,285 | |
| Mar 23, 2026 | Theresa Heggie | $504,823 | |
| Dec 02, 2025 | Alane Barnes | $367,032 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Entrypoint Capital, Llc | €98,989 | |
| Dec 31, 2025 | Graham Capital Management, L.p. | €654,232 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | €1,837,461 | |
| Dec 31, 2025 | Hussman Strategic Advisors Inc | €1,965,600 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 17,805,504 | Institution | 6.97% | 150,278,454 |
| Peter Kolchinsky | 15,827,186 | Institution | 6.19% | 133,581,450 |
| Vanguard Index Funds | 15,488,613 | Institution | 6.06% | 130,723,894 |
| James E. Flynn | 15,096,403 | Institution | 5.91% | 127,413,641 |
| Ishares | 11,868,938 | Institution | 4.64% | 100,173,837 |
| Joseph Edelman | 10,308,888 | Institution | 4.03% | 87,007,015 |
| Spdr | 8,024,073 | Institution | 3.14% | 67,723,176 |
| Tiaa-cref Funds | 4,314,998 | Institution | 1.69% | 36,418,583 |
| Felix Baker | 2,822,727 | Institution | 1.10% | 23,823,816 |
| Vanguard Horizon Funds | 2,812,056 | Institution | 1.10% | 23,733,753 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 15,488,613 | Institution | 6.06% | 130,723,894 |
| Tiaa-cref Funds | 4,314,998 | Institution | 1.69% | 36,418,583 |
| Vanguard Horizon Funds | 2,812,056 | Institution | 1.10% | 23,733,753 |
| Fidelity Salem Street Trust | 2,793,558 | Institution | 1.09% | 23,577,630 |
| Fidelity Concord Street Trust | 2,501,697 | Institution | 0.98% | 21,114,323 |
| Vanguard Scottsdale Funds | 1,607,933 | Institution | 0.63% | 13,570,955 |
| Vanguard Explorer Fund | 1,341,254 | Institution | 0.52% | 11,320,184 |
| Schwab Capital Trust | 1,097,231 | Institution | 0.43% | 9,260,630 |
| Blackrock Funds | 1,024,936 | Institution | 0.40% | 8,650,460 |
| Dfa Investment Dimensions Group Inc | 831,862 | Institution | 0.33% | 7,020,915 |
FAQ
Who Owns BioCryst (DE:BO1)?
According to the latest TipRanks data, approximately 35.22% of the company's stock is held by institutional investors, 1.47% is held by insiders, and 63.31% is held by public companies and individual investors.
What percentage of BioCryst (DE:BO1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.22% of BioCryst (DE:BO1) stock is held by institutional investors: 15.39% by mutual funds, 18.95% by ETFs and 0.87% by other institutional investors.
What percentage of BioCryst (DE:BO1) stock is held by retail investors?
According to the latest TipRanks data, approximately 63.31% of BioCryst (DE:BO1) stock is held by public companies and individual investors.
Who owns the most shares of BioCryst (DE:BO1)?
Vanguard owns the most shares of BioCryst (DE:BO1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.